Vor Biopharma (VOR) EBIT (2020 - 2026)
Vor Biopharma's (VOR) quarterly EBIT came in at -$35.2 million in Q1 2026, down 5.61% year-on-year from -$37.3 million in Q1 2025, and up 2.22% on a QoQ basis from -$36.0 million in Q4 2025.
Vor Biopharma (VOR) EBIT (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of EBIT data on file, last reported at -$35.2 million in Q1 2026.
- On a quarterly basis, EBIT fell 5.61% year-over-year to -$35.2 million in Q1 2026; TTM through Mar 2026 was -$373.5 million, a 205.78% decrease from a year earlier, with the FY2025 full-year figure at -$371.6 million, down 206.67% from the prior year.
- EBIT for Q1 2026 stood at -$35.2 million, up from -$36.0 million in the prior quarter.
- Over the last five years, EBIT for VOR reached as high as -$21.8 million in Q2 2022 and fell as low as -$274.3 million in Q2 2025.
- Historically, EBIT has averaged -$44.0 million across 5 years, with a median of -$30.4 million in 2023.
- Across the five-year window, EBIT rose 19.26% in 2024 and tumbled 844.67% in 2025, its largest moves.
- Year by year, EBIT stood at -$24.7 million in 2022, then dropped by 13.75% to -$28.1 million in 2023, then declined by 11.33% to -$31.3 million in 2024, then slipped by 14.85% to -$36.0 million in 2025, then rose by 2.22% to -$35.2 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$35.2 million in Q1 2026, -$36.0 million in Q4 2025, and -$28.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Vor Biopharma | 187.37 Mn | 187.37 Mn | - | -35.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.16 Mn |
| Dec 31, 2025 | -35.96 Mn |
| Sep 30, 2025 | -28.11 Mn |
| Jun 30, 2025 | -274.28 Mn |
| Mar 31, 2025 | -33.29 Mn |
| Dec 31, 2024 | -31.31 Mn |
| Sep 30, 2024 | -28.51 Mn |
| Jun 30, 2024 | -29.04 Mn |
| Mar 31, 2024 | -32.33 Mn |
| Dec 31, 2023 | -28.12 Mn |
| Sep 30, 2023 | -35.32 Mn |
| Jun 30, 2023 | -32.17 Mn |
| Mar 31, 2023 | -30.42 Mn |
| Dec 31, 2022 | -24.73 Mn |
| Sep 30, 2022 | -24.10 Mn |
| Jun 30, 2022 | -21.79 Mn |
| Mar 31, 2022 | -22.80 Mn |
| Dec 31, 2021 | -18.31 Mn |
| Sep 30, 2021 | -18.60 Mn |
| Jun 30, 2021 | -18.38 Mn |